Kynurenic acid in schizophrenia: a systematic review and meta-analysis E Plitman, Y Iwata, F Caravaggio, S Nakajima, JK Chung, P Gerretsen, ... Schizophrenia bulletin 43 (4), 764-777, 2017 | 209 | 2017 |
Individual determinants of COVID-19 vaccine hesitancy P Gerretsen, J Kim, F Caravaggio, L Quilty, M Sanches, S Wells, ... PloS one 16 (11), e0258462, 2021 | 150 | 2021 |
Glutamatergic neurometabolite levels in patients with ultra-treatment-resistant schizophrenia: a cross-sectional 3T proton magnetic resonance spectroscopy study Y Iwata, S Nakajima, E Plitman, F Caravaggio, J Kim, P Shah, W Mar, ... Biological psychiatry 85 (7), 596-605, 2019 | 109 | 2019 |
Insight and medication adherence in schizophrenia: An analysis of the CATIE trial J Kim, M Ozzoude, S Nakajima, P Shah, F Caravaggio, Y Iwata, ... Neuropharmacology 168, 107634, 2020 | 92 | 2020 |
The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: a systematic review P Shah, Y Iwata, E Plitman, EE Brown, F Caravaggio, J Kim, S Nakajima, ... Psychiatry research 268, 114-122, 2018 | 77 | 2018 |
Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of 1H-MRS studies Y Iwata, S Nakajima, E Plitman, Y Mihashi, F Caravaggio, JK Chung, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 86, 340-352, 2018 | 59 | 2018 |
A meta-analysis of transcranial direct current stimulation for schizophrenia:“Is more better?” J Kim, Y Iwata, E Plitman, F Caravaggio, JK Chung, P Shah, ... Journal of psychiatric research 110, 117-126, 2019 | 53 | 2019 |
Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study P Shah, Y Iwata, EE Brown, J Kim, M Sanches, H Takeuchi, S Nakajima, ... European Archives of Psychiatry and Clinical Neuroscience 270, 11-22, 2020 | 41 | 2020 |
Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicity P Shah, E Plitman, Y Iwata, J Kim, S Nakajima, N Chan, EE Brown, ... Journal of psychiatric research 124, 151-158, 2020 | 36 | 2020 |
Alterations in body mass index and waist-to-hip ratio in never and minimally treated patients with psychosis: a systematic review and meta-analysis P Shah, Y Iwata, F Caravaggio, E Plitman, EE Brown, J Kim, N Chan, ... Schizophrenia Research 208, 420-429, 2019 | 35 | 2019 |
Gender and pathology-specific effect of Apolipoprotein E genotype on psychosis in Alzheimer’s disease J Kim, C E Fischer, T A Schweizer, D G Munoz Current Alzheimer Research 14 (8), 834-840, 2017 | 27 | 2017 |
What proportion of striatal D2 receptors are occupied by endogenous dopamine at baseline? A meta-analysis with implications for understanding antipsychotic occupancy F Caravaggio, Y Iwata, J Kim, P Shah, P Gerretsen, G Remington, ... Neuropharmacology 163, 107591, 2020 | 18 | 2020 |
The role of cerebrovascular disease on cognitive and functional status and psychosis in severe Alzheimer’s disease J Kim, TA Schweizer, CE Fischer, DG Munoz Journal of Alzheimer's Disease 55 (1), 381-389, 2017 | 18 | 2017 |
Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disorders J Kim, E Plitman, Y Iwata, S Nakajima, W Mar, R Patel, S Chavez, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 99, 109839, 2020 | 17 | 2020 |
Resting-state functional connectivity in treatment response and resistance in schizophrenia: a systematic review NK Chan, J Kim, P Shah, EE Brown, E Plitman, F Carravaggio, Y Iwata, ... Schizophrenia research 211, 10-20, 2019 | 17 | 2019 |
Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study E Plitman, S Chavez, S Nakajima, Y Iwata, JK Chung, F Caravaggio, ... Psychiatry Research: Neuroimaging 273, 16-24, 2018 | 17 | 2018 |
Modulation of brain activity with transcranial direct current stimulation: targeting regions implicated in impaired illness awareness in schizophrenia J Kim, E Plitman, S Nakajima, Y Alshehri, Y Iwata, JK Chung, ... European Psychiatry 61, 63-71, 2019 | 15 | 2019 |
The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [11C]‐raclopride and [11C … F Caravaggio, J Ku Chung, E Plitman, I Boileau, P Gerretsen, J Kim, ... Human brain mapping 38 (11), 5519-5534, 2017 | 15 | 2017 |
Glutathione levels and glutathione-glutamate correlation in patients with treatment-resistant schizophrenia Y Iwata, S Nakajima, E Plitman, P Truong, A Bani-Fatemi, F Caravaggio, ... Schizophrenia Bulletin Open 2 (1), sgab006, 2021 | 14 | 2021 |
Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning F Caravaggio, P Gerretsen, W Mar, JK Chung, E Plitman, S Nakajima, ... Psychoneuroendocrinology 81, 80-87, 2017 | 14 | 2017 |